O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma

O‐GlcNAcylation is a key post‐translational modification that modifies the functions of proteins. Associations between O‐GlcNAcylation, shorter survival of cholangiocarcinoma (CCA) patients, and increased migration/invasion of CCA cell lines have been reported. However, the specific O‐GlcNAcylated proteins (OGPs) that participate in promotion of CCA progression are poorly understood. OGPs were isolated from human CCA cell lines, KKU‐213 and KKU‐214, using a click chemistry‐based enzymatic labeling system, identified using LC‐MS/MS, and searched against an OGP database. From the proteomic analysis, a total of 21 OGPs related to cancer progression were identified, of which 12 have not been previously reported. Among these, hnRNP‐K, a multifaceted RNA‐ and DNA‐binding protein known as a pre‐mRNA‐binding protein, was one of the most abundantly expressed, suggesting its involvement in CCA progression. O‐GlcNAcylation of hnRNP‐K was further verified by anti‐OGP/anti‐hnRNP‐K immunoprecipitations and sWGA pull‐down assays. The perpetuation of CCA by hnRNP‐K was evaluated using siRNA, which revealed modulation of cyclin D1, XIAP, EMT markers, and MMP2 and MMP7 expression. In native CCA cells, hnRNP‐K was primarily localized in the nucleus; however, when O‐GlcNAcylation was suppressed, hnRNP‐K was retained in the cytoplasm. These data signify an association between nuclear accumulation of hnRNP‐K and the migratory capabilities of CCA cells. In human CCA tissues, expression of nuclear hnRNP‐K was positively correlated with high O‐GlcNAcylation levels, metastatic stage, and shorter survival of CCA patients. This study demonstrates the significance of O‐GlcNAcylation on the nuclear translocation of hnRNP‐K and its impact on the progression of CCA.

[1]  E. Lam,et al.  O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1 , 2018, Oncogene.

[2]  S. Kang,et al.  O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression , 2017, Molecules and cells.

[3]  L. Liang,et al.  Down‐regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2 , 2017, International journal of cancer.

[4]  K. Sawanyawisuth,et al.  High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation , 2017, Scientific Reports.

[5]  Tianxin Lin,et al.  Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer , 2016, Journal of cellular and molecular medicine.

[6]  B. Weimer,et al.  Salmonella Typhimurium Enzymatically Landscapes the Host Intestinal Epithelial Cell (IEC) Surface Glycome to Increase Invasion* , 2016, Molecular & Cellular Proteomics.

[7]  Y. Lao,et al.  Nujiangexathone A, a novel compound from Garcinia nujiangensis, suppresses cervical cancer growth by targeting hnRNPK. , 2016, Cancer letters.

[8]  J. Zuo,et al.  TCP10L synergizes with MAD1 in transcriptional suppression and cell cycle arrest through mutual interaction , 2016, BMB reports.

[9]  Fan Zhang,et al.  Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. , 2016, Cancer letters.

[10]  C. Lebrilla,et al.  Quantitation of Site-Specific Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs. , 2016, Analytical chemistry.

[11]  K. Sawanyawisuth,et al.  Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB , 2016, Scientific Reports.

[12]  Feng-Hou Gao,et al.  Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression. , 2016, Biomedical reports.

[13]  D. Sinclair,et al.  O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway , 2016, Oncogene.

[14]  I. Ng,et al.  Phosphorylation of nucleophosmin at threonine 234/237 is associated with HCC metastasis. , 2015, Oncotarget.

[15]  C. Lebrilla,et al.  Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes* , 2015, Molecular & Cellular Proteomics.

[16]  Tong Wang,et al.  Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells , 2015, Oncotarget.

[17]  Li Gang,et al.  Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells , 2015, PloS one.

[18]  B. Chabot,et al.  Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis , 2015, BMC Cancer.

[19]  Y. Kawasaki,et al.  Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells. , 2015, Biochemical and biophysical research communications.

[20]  Xiaoyong Yang,et al.  O-GlcNAc signaling in cancer metabolism and epigenetics. , 2015, Cancer letters.

[21]  Yanhong Li,et al.  Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway , 2014, Journal of experimental & clinical cancer research : CR.

[22]  S. Kaul,et al.  Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence , 2014, BMC Cancer.

[23]  J. Vishwanatha,et al.  Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies , 2014, British Journal of Cancer.

[24]  N. Ferrari,et al.  Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression. , 2014, Cancer letters.

[25]  P. Unger,et al.  Histone H1.5, a novel prostatic cancer marker: an immunohistochemical study. , 2014, Human pathology.

[26]  Hushan Yang,et al.  CD147-CD98hc Complex Contributes to Poor Prognosis of Non-Small Cell Lung Cancer Patients Through Promoting Cell Proliferation Via the PI3K/Akt Signaling Pathway , 2014, Annals of Surgical Oncology.

[27]  Ying Liang,et al.  Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma , 2014, BMC Cancer.

[28]  F. Boccardo,et al.  Prostate cancer: prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression. , 2014, International journal of oncology.

[29]  Atsushi B. Tsuji,et al.  AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. , 2014, International journal of oncology.

[30]  Jau-Chen Lin,et al.  The Antitumor Agent PBT-1 Directly Targets HSP90 and hnRNP A2/B1 and Inhibits Lung Adenocarcinoma Growth and Metastasis , 2014, Journal of medicinal chemistry.

[31]  J. Turnay,et al.  4F2hc-silencing impairs tumorigenicity of HeLa cells via modulation of galectin-3 and β-catenin signaling, and MMP-2 expression. , 2013, Biochimica et biophysica acta.

[32]  K. Vosseller,et al.  O-GlcNAc in cancer biology , 2013, Amino Acids.

[33]  Bei Wang,et al.  hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors. , 2013, Carcinogenesis.

[34]  C. Srisomsap,et al.  Proteomic analysis and abrogated expression of O‐GlcNAcylated proteins associated with primary breast cancer , 2013, Proteomics.

[35]  T. Conrads,et al.  Progesterone Enhances Calcitriol Antitumor Activity by Upregulating Vitamin D Receptor Expression and Promoting Apoptosis in Endometrial Cancer Cells , 2013, Cancer Prevention Research.

[36]  Nashi Widodo,et al.  Heterogeneous Nuclear Ribonucleoprotein K (hnRNP-K) Promotes Tumor Metastasis by Induction of Genes Involved in Extracellular Matrix, Cell Movement, and Angiogenesis , 2013, The Journal of Biological Chemistry.

[37]  T. Lefebvre,et al.  Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition. , 2012, Biochimica et biophysica acta.

[38]  E. Sterchi,et al.  Meprinα Transactivates the Epidermal Growth Factor Receptor (EGFR) via Ligand Shedding, thereby Enhancing Colorectal Cancer Cell Proliferation and Migration* , 2012, The Journal of Biological Chemistry.

[39]  H. Klocker,et al.  Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. , 2012, Carcinogenesis.

[40]  T. Lefebvre,et al.  The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation. , 2012, American journal of physiology. Endocrinology and metabolism.

[41]  M. Reginato,et al.  Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis* , 2012, The Journal of Biological Chemistry.

[42]  G. Hart,et al.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. , 2011, Annual review of biochemistry.

[43]  Hongfang Liu,et al.  dbOGAP - An Integrated Bioinformatics Resource for Protein O-GlcNAcylation , 2011, BMC Bioinformatics.

[44]  Jianxing He,et al.  Subcellular proteomics revealed the epithelial–mesenchymal transition phenotype in lung cancer , 2011, Proteomics.

[45]  Feng Han,et al.  Tumor and Stem Cell Biology Cancer Research GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis , 2010 .

[46]  A. Bhattacharyya,et al.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53 , 2010, International journal of cancer.

[47]  Jürgen Roth,et al.  O-GlcNAc Protein Modification in Cancer Cells Increases in Response to Glucose Deprivation through Glycogen Degradation* , 2009, The Journal of Biological Chemistry.

[48]  E. Kang,et al.  NFκB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions , 2008, Proceedings of the National Academy of Sciences.

[49]  A. Jimeno,et al.  Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer , 2008, Molecular Cancer Therapeutics.

[50]  W. Wang,et al.  UTRN on chromosome 6q24 is mutated in multiple tumors , 2007, Oncogene.

[51]  Y. Li,et al.  Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells , 2007, Cancer biology & therapy.

[52]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[53]  G I Murray,et al.  Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer , 2006, British Journal of Cancer.

[54]  G. Hart,et al.  Cell signaling, the essential role of O-GlcNAc! , 2006, Biochimica et biophysica acta.

[55]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[56]  D. Stolz,et al.  Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT , 2004, Transplantation.

[57]  H. Leffers,et al.  Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. , 1996, European journal of biochemistry.

[58]  I. Khalaila,et al.  The effect of O‐GlcNAcylation on hnRNP A1 translocation and interaction with transportin1 , 2017, Experimental cell research.

[59]  C. Wongkham,et al.  Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[60]  G. Hart,et al.  Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. , 2007, Nature.

[61]  S. Wagner,et al.  Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. , 2004, Cancer letters.

[62]  G. Hart,et al.  Analytical methods for the study of O-GlcNAc glycoproteins and glycopeptides. , 1998, Methods in molecular biology.